ATE326456T1 - 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten- 1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie - Google Patents

3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten- 1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie

Info

Publication number
ATE326456T1
ATE326456T1 AT03808761T AT03808761T ATE326456T1 AT E326456 T1 ATE326456 T1 AT E326456T1 AT 03808761 T AT03808761 T AT 03808761T AT 03808761 T AT03808761 T AT 03808761T AT E326456 T1 ATE326456 T1 AT E326456T1
Authority
AT
Austria
Prior art keywords
benzyl
heteroarylmethylamine
cyclopenten
cyclopent
schizophrenia
Prior art date
Application number
AT03808761T
Other languages
English (en)
Inventor
Bernard Vacher
Stephane Cuisiat
Wouter Koek
Francis Colpaert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE326456T1 publication Critical patent/ATE326456T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/548Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings having unsaturation outside the six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/55Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/48Aldehydo radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT03808761T 2002-10-16 2003-10-16 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten- 1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie ATE326456T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212854A FR2845992B1 (fr) 2002-10-16 2002-10-16 Derives de 3-(cyclopenten-1yl)-benzyl-ou3-(cyclopenten-1yl)- heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie

Publications (1)

Publication Number Publication Date
ATE326456T1 true ATE326456T1 (de) 2006-06-15

Family

ID=32050432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03808761T ATE326456T1 (de) 2002-10-16 2003-10-16 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten- 1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie

Country Status (16)

Country Link
US (2) US7163957B2 (de)
EP (1) EP1551821B1 (de)
JP (1) JP4566749B2 (de)
CN (1) CN1319962C (de)
AT (1) ATE326456T1 (de)
AU (1) AU2003301277B2 (de)
BR (1) BR0315365A (de)
CA (1) CA2502528C (de)
DE (1) DE60305339T2 (de)
ES (1) ES2264780T3 (de)
FR (1) FR2845992B1 (de)
HK (1) HK1073112A1 (de)
MX (1) MXPA05004114A (de)
PT (1) PT1551821E (de)
WO (1) WO2004035561A1 (de)
ZA (1) ZA200503822B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2898601A1 (fr) * 2006-03-14 2007-09-21 Pierre Fabre Medicament Sa Procede de preparation de derives (2-(2,3-dihydro-benzofuran ou benzofuran-7-yloxy)-ethyl)-(3-cyclopenten-1-yl-benzyl) amines et intermediaire de synthese
US20090288701A1 (en) * 2008-05-23 2009-11-26 E.I.Du Pont De Nemours And Company Solar cell laminates having colored multi-layer encapsulant sheets

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05125024A (ja) * 1991-11-05 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアリールオキシアルキルアミン誘導体又はその塩
JPH05255302A (ja) * 1992-03-09 1993-10-05 Yamanouchi Pharmaceut Co Ltd 新規なクロマニルオキシアルキルアミン誘導体
US5955495A (en) * 1996-05-03 1999-09-21 Hoffmann-La Roche Inc. Method of treating diseases of the CNS
WO1998008819A1 (en) * 1996-08-27 1998-03-05 American Home Products Corporation 4-aminoethoxy indolone derivatives
WO1999051575A1 (en) * 1998-04-08 1999-10-14 American Home Products Corporation N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
SK17212000A3 (sk) * 1998-05-14 2001-05-10 Egis Gy�Gyszergy�R Rt. Benzofuránové deriváty, farmaceutické kompozície ich obsahujúce a spôsob prípravy aktívnej zložky
FR2791676B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveaux derives de [(2-substitue-5-[thienyl])-benzyl]- [2-([isopropoxy-5-fluoro]-phenoxy) ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments

Also Published As

Publication number Publication date
EP1551821A1 (de) 2005-07-13
AU2003301277B2 (en) 2009-06-18
AU2003301277A1 (en) 2004-05-04
ZA200503822B (en) 2006-03-29
JP2006508080A (ja) 2006-03-09
CN1705653A (zh) 2005-12-07
ES2264780T3 (es) 2007-01-16
WO2004035561A1 (fr) 2004-04-29
PT1551821E (pt) 2006-09-29
FR2845992A1 (fr) 2004-04-23
US20060264471A1 (en) 2006-11-23
CN1319962C (zh) 2007-06-06
CA2502528A1 (fr) 2004-04-29
MXPA05004114A (es) 2005-06-22
BR0315365A (pt) 2005-08-23
DE60305339T2 (de) 2007-02-01
EP1551821B1 (de) 2006-05-17
US20060014827A1 (en) 2006-01-19
CA2502528C (fr) 2011-12-13
JP4566749B2 (ja) 2010-10-20
US7163957B2 (en) 2007-01-16
HK1073112A1 (en) 2005-09-23
DE60305339D1 (de) 2006-06-22
US7235568B2 (en) 2007-06-26
FR2845992B1 (fr) 2005-02-04

Similar Documents

Publication Publication Date Title
ATE447562T1 (de) Verstärker von glutamat-rezeptoren
TW200510441A (en) Novel compounds
DK1277736T3 (da) Hidtil ukendte bicykliske forbindelser
CY1108228T1 (el) Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως
HUP0103988A2 (en) New d3-dopamine receptor selective piperazine and piperidine compounds, process for their preparation, their and pharmaceutical compositions containing them
DE69617731T2 (de) Neue heterozyklische derivate und ihre medizinische anwendung
DK1349843T3 (da) Thiazol- og oxazolderivater som aktivatorer af human peroxisom profilerator-aktiverede receptorer
NO20000521D0 (no) 1-(N-fenylaminoalkyl)-piperazin derivater substituert i posisjon 2 på fenylringen
EA200500037A1 (ru) Фенилбензамиды
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
DE60111464D1 (de) Azabicycloalkan-Derivate zur Verwendung als Inhibitoren der Serotonin-Wiederaufnahme und als 5HT2a Antagonisten
DE602004023185D1 (de) Phenylsulfonderivate und deren verwendung bei der behandlung von zns-erkrankungen
ATE326456T1 (de) 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten- 1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ATE455769T1 (de) Substituierte thiazole und ihre verwendung zur herstellung von arzneimitteln
DE60020246D1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
BR0104344A (pt) Análagos de fenoxazina úteis como inibidores de agregação amilóide e tratamento da doença de alzheimer e de disfunções relacionadas com a amiloidose
DE60006125D1 (de) Herstellung von 2-(2-arylmorpholin-2-yl)ethanolderivaten und zwischenprodukte
DE60308663D1 (de) Verwendung eines neuen mittels zur verhütung von infektionen
DE60332851D1 (de) Indolinverbindung und deren medizinische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties